Isla P. Garraway, MD, PhD

Isla Garraway, MD, PhD

Professor, Department of Urology
Physician, Department of Urology





Institutional Affiliation

Ronald Reagan UCLA Medical Center



Surgery and Urology, UCLA Medical Center, 1999-2003


PhD, UCLA , 1999
MD, UCLA School of Medicine, 1999


Surgery and Urology, UCLA Medical Center, 2003-2005

Board Certification

Urology, American Board of Urology, 2009

Contact Information

Clinical Interests

Bladder Cancer, Oncology, Prostate Cancer

Scientific Interests

Dr. Isla Garraway's research focuses on mouse model development for the study of prostate and bladder cancer imaging and response to treatment.

Highlighted Publications

Guo C, Liu H, Zhang BH, Cadaneanu RM, Mayle AM, Garraway IP. Epcam, CD44, and CD49f distinguish sphere-forming human prostate basal cells from a subpopulation with predominant tubule initiation capability. PLoS One. 2012 Apr 13;7(4):e34219.

Goldstein AS, Huang J, Guo C, Garraway IP, Witte ON. Identification of a cell of origin for human prostate cancer. Science. 2010 Jul 30;329(5991):568-71.

Klatte T, Seligson DB, Rao JY, Yu H, de Martino M, Garraway I, Wong SG, Belldegrun AS, Pantuck AJ. Absent CD44v6 expression is an independent predictor of poor urothelial bladder cancer outcome. J Urol. 2010 Jun;183(6):2403-8. Epub 2010 Apr 18

Garraway IP, Sun W, Tran CP, Perner S, Zhang B, Goldstein AS, Hahm SA, Haider M, Head CS, Reiter RE, Rubin MA, Witte ON. Human prostate sphere-forming cells represent a subset of basal epithelial cells capable of glandular regeneration in vivo. Prostate. 2010 Apr 1;70(5):491-501.

Goldstein AS, Lawson DA, Cheng D, Sun W, Garraway IP, Witte ON. Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristics. Proc Natl Acad Sci U S A. 2008 Dec 30;105(52):20882-7. Epub 2008 Dec 16